Longevity Aeovian lands $55m to advance pipeline focused on mTOR biologyBy adminDecember 16, 20250 Initial focus on epilepsy could drive progress in aging and healthspan therapeutics targeting the mTOR pathway. US biotech Aeovian Pharmaceuticals…
